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AbstrACt
Objectives To assess whether chronic kidney disease 
of unknown aetiology (CKDu) is present in India and to 
identify risk factors for it using population-based data and 
standardised methods.
Design Secondary data analysis of three population-
based cross-sectional studies conducted between 2010 
and 2014.
setting Urban and rural areas of Northern India (states 
of Delhi and Haryana) and Southern India (states of Tamil 
Nadu and Andhra Pradesh).
Participants 12 500 individuals without diabetes, 
hypertension or heavy proteinuria.
Outcome measures Mean estimated glomerular filtration 
rate (eGFR) and prevalence of eGFR below 60 mL/min 
per 1.73 m2 (eGFR <60) in individuals without diabetes, 
hypertension or heavy proteinuria (proxy definition of CKDu).
results The mean eGFR was 105.0±17.8 mL/min per 
1.73 m2. The prevalence of eGFR <60 was 1.6% (95% 
CI=1.4 to 1.7), but this figure varied markedly between 
areas, being highest in rural areas of Southern Indian 
(4.8% (3.8 to 5.8)). In Northern India, older age was the 
only risk factor associated with lower mean eGFR and 
eGFR <60 (regression coefficient (95% CI)=−0.94 (0.97 
to 0.91); OR (95% CI)=1.10 (1.08 to 1.11)). In Southern 
India, risk factors for lower mean eGFR and eGFR 
<60, respectively, were residence in a rural area (−7.78 
(-8.69 to –6.86); 4.95 (2.61 to 9.39)), older age (−0.90 
(–0.93 to –0.86); 1.06 (1.04 to 1.08)) and less education 
(−0.94 (-1.32 to –0.56); 0.67 (0.50 to 0.90) for each 
5 years at school).
Conclusions CKDu is present in India and is not confined 
to Central America and Sri Lanka. Identified risk factors are 
consistent with risk factors previously reported for CKDu in 
Central America and Sri Lanka.
IntrODuCtIOn  
High prevalence of chronic kidney disease 
of unknown aetiology (CKDu) has mainly 
been reported in the last decades among 
the working age populations of agricul-
tural communities of tropical/subtropical 
regions, specifically in Central America and 
Sri Lanka.1–3 In Nicaragua and El Salvador, 
the estimated prevalence of estimated 
glomerular filtration rate (eGFR; the clin-
ical measure of kidney function) below 
60 mL/min per 1.73 m2 (eGFR <60), in the 
absence of diabetes and hypertension, was 
10%–20%.4–6 It has been suggested that 
CKDu may also be highly prevalent in other 
low-income and middle-income countries 
(LMICs), including India.7–11 However, it is 
not clear in which other regions of the world 
CKDu occurs, whether the underlying aeti-
ology is the same in different regions and 
what the risk factors are. Currently, there is 
no consensus, but factors such as heat stress, 
strengths and limitations of this study
 ► The use of a random selection of population-based 
participants allows the estimation of chronic kidney 
disease of unknown aetiology (CKDu) prevalence in 
the general population.
 ► A large sample size including participants from dif-
ferent areas of India (urban and rural, and Northern 
and Southern India) increases the representative-
ness of the results.
 ► The use of standardised definitions of CKDu facili-
tates international comparisons of CKDu prevalence 
and risk factors.
 ► The prevalence of estimated glomerular filtration 
rate <60 observed in this study is likely to be under-
estimated; however, this is unlikely to have biased 
the internal comparisons conducted in this study.
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strenuous work, climatic conditions, agrochemical use, 
heavy metal exposure and infections have been suggested 
as risk factors.1 12–15 
Data on CKDu from India are scarce. The recent report 
of verbal autopsy data from India suggests CKD of all 
causes is a growing problem. However, it does not provide 
accurate population-based data on CKDu.16 17 Existing 
reports indicate that CKDu may be common but it is diffi-
cult to be definite about this because of the absence of 
population-based studies using standardised and compa-
rable methods. Data from the Indian CKD Registry, a 
hospital based registry of incident cases of CKD between 
2006 and 2010, found that CKDu was the second most 
common form of CKD after diabetic nephropathy.10 
However, this is restricted to referred cases and there-
fore may not be representative of the general population. 
There are also sporadic reports of high numbers of CKDu 
cases among agricultural communities of the South 
Eastern Indian states of Andhra Pradesh and Odisha 
(reviewed by Chatterejee18 and Ganguli19). However, 
population-based data have not been reported for India.
We conducted a secondary analysis of represen-
tative sample surveys conducted in India between 
2010 and 2014. Given the absence of a clear case defini-
tion for CKDu it is necessary to make a presumptive diag-
nosis based on measures/estimates of GFR in the absence 
of known risk factors for kidney disease. The overall aim 
of the current study was to use a methodology which is 
comparable with previous studies elsewhere in the world 
(particularly in Central America) to assess the extent to 
which reduced kidney function is a problem in India, and 
which areas and subpopulations are most affected. We 
therefore: (1) assessed the distribution eGFR and preva-
lence of eGFR below 60 mL/min per 1.73 m2 (eGFR <60) 
in Indian populations restricted to those without known 
risk factors for CKD, i.e. diabetes, hypertension or heavy 
proteinuria; (2) compared these outcomes in North and 
South India and in urban and rural populations; and (3) 
identified the risk factors associated with these outcomes.
MethODs
study population
We used cross-sectional data from three population-based 
studies conducted in India: the ‘Centre for Cardiometa-
bolic Risk Reduction in South Asia’ cohort study (CARRS 
study),20 the ‘Implementing a comprehensive diabetes 
prevention and management program’ study (UDAY 
study)21 and the ‘Prevalence of Coronary Heart Disease 
repeat survey’ study funded by the Indian Council of 
Medical Research (ICMR-CHD study).22 Details on study 
design and selection of participants from the CARRS, 
UDAY and ICMR-CHD studies have been previously 
described20–22 and are summarised in table 1.
For the current analyses, we excluded participants with 
missing information on serum creatinine, as this vari-
able was necessary to estimate eGFR. As the focus of our 
study was CKDu, we excluded participants with known 
risk factors for CKD (ie, diabetes and hypertension) or 
evidence of primary glomerular disease (as assessed by 
heavy proteinuria) or with missing information for these 
risk factors. We also excluded participants with missing 
information on basic covariables (education) for all 
the analyses conducted. A study flowchart is presented. 
We classified participants as having: diabetes, if plasma 
fasting glucose was ≥126 mg/dL or glycated haemoglobin 
A1c (HbA1c) was ≥6.5% or self-reported diabetes; hyper-
tension, if systolic blood pressure was ≥140 mm Hg or 
diastolic blood pressure was ≥90 mm Hg or self-reported 
hypertension; and heavy proteinuria, if the albumin:cre-
atinine ratio (ACR) in urine was ≥300 mg/g. We used the 
CKD-EPI equation to estimate GFR.23
Data collection and laboratory analyses
Data collection was conducted between October 2010 
and December 2014. All three studies used a standardised 
questionnaire to collect data on age, sex, completed years 
of education (0, ≤5, >5–≤10, >10), alcohol intake (ever, 
never) and dietary habits (vegetarian yes, no). Weight, 
height and body composition were measured using stadi-
ometers (SECA 214 in the three studies) and electronic 
bioimpedance measuring instruments (Tanita BC 418 in 
CARRS and ICMR-CHD studies, and Tanita BC 601 in 
UDAY study). Body mass index (BMI, kg/m2) was calcu-
lated and categorised (≤18.5: underweight; >18.5–≤25: 
normal weight; >25–≤30: overweight;>30: obese) and fat 
free mass was derived from bioelectric impedance anal-
ysis. In CARRS and ICMR-CHD studies, fat-free mass 
(kg) was directly measured as previously described,24 
whereas in UDAY study, fat free mass was estimated from 
the percentage of total body fat. To estimate fat-free 
mass from the percentage of body fat, we calculated the 
amount of total body fat by multiplying the percentage 
of body fat by the weight of the participant, and from 
that value we estimated the amount of fat-free mass by 
subtracting the weight of total body fat from the total 
weight of the participant. Blood pressure was measured 
using electronic sphygmomanometers (OMRON (HEM-
7080) in CARRS and ICMR-CHD studies, and OMRON 
(HEM 7200) in UDAY study), as previously reported.20 25 
Stadiometers, electronic bioimpedance measuring instru-
ments, and electronic sphygmomanometers were cali-
brated before each study, and no re-calibration was 
needed during the duration of different studies. A fasting 
venous blood sample was used to measure glucose levels, 
HbA1c and serum creatinine levels and urine sample to 
measure albuminuria and creatinuria.20 Glucose levels 
were measured using hexokinase/kinetic methods, 
HbA1c using high-performance liquid chromatography, 
serum creatinine using the rate-blanked and compen-
sated kinetic Jaffe method, traceable to isotope dilu-
tion mass spectrometry and albuminuria using immune 
turbidmetric method.20 Samples from UDAY, ICMR-CHD 
and samples from CARRS from Delhi were analysed at 
Public Health Foundation of India (PHFI) laboratory 
and samples from CARRS from Chennai were analysed 
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at Madras Diabetes Research Foundation (MDRF) labo-
ratory. Both PHFI and MDRF laboratories used the same 
methodologies and protocols to analyse the samples and 
participated in Randox International Quality Assurance 
Scheme for clinical chemistry and HbA1c during the 
entire study periods. Data from the three studies were 
homogenised and merged in a single data set.
statistical analyses
We reported mean eGFR and prevalence of eGFR <60 
according to different characteristics of the study popu-
lations. UDAY and CARRS studies did not involve fully 
random population samples (since sampling was based 
on households, with one participant per household) 
and the proportions of study participants with particular 
outcomes (eg, eGFR <60), will not be exactly the same 
(but very similar) to what would have been obtained with 
genuine random population samples; thus in this paper 
we refer to the prevalence in the study participants, not 
overall population prevalence estimates. We used linear 
regression models to estimate the associations between 
potential risk factors and eGFR and logistic regression 
models to estimate the associations between potential 
risk factors and eGFR <60. We also repeated the analyses 
separately for males and females. Variables associated 
with eGFR in the basic analyses (adjusted for age and 
sex) were considered for the multiple regression analysis. 
In the final multiple regression model, we included all 
variables that were of a priori interest and/or had shown 
independent associations with eGFR. We then checked 
for multicollinearity for each variable in the multiple 
regression analyses in comparison with the basic anal-
yses.26 Six per cent of participants had missing values 
for basic co-variables (ie, education) and were excluded 
from the analysis; 5% and 9% of participants had missing 
values for BMI and for fat-free mass, respectively. These 
participants were included in the main analysis, but we 
excluded them to compare models non-adjusted and 
adjusted for these variables. We calculated prevalence 
ratios of eGFR <60 for rural versus urban areas in different 
age groups. Urban areas were defined as ‘all places with 
a municipality, corporation, cantonment board or noti-
fied town area committee, etc., and all other places which 
satisfied the following criteria: a minimum population of 
5,000; at least 75 per cent of the male main working popu-
lation engaged in non-agricultural pursuits; and a density 
of population of at least 400 persons per km2, according 
to the 2011 Census of India definition.27 Finally, we esti-
mated potential interactions between urban (versus 
rural) residence and latitude (Northern India (ie, states 
of Delhi and Haryana) versus Southern India (states of 
Tamil Nadu and Andhra Pradesh). Classification of lati-
tude was done in concordance with the classification of 
major geographical areas on India defined by the ICMR.28 
We conducted all analyses using Stata V.14 (StataCorp).
Patient and public involvement
Patients were not involved in the design of this analysis.
results
Characteristics of study participants
A total of 12 500 people were eligible for the current anal-
yses (figure 1). Table 2 summarises the sociodemographic 
and anthropometric characteristics of the 12 500 study 
participants included in this analysis (the same informa-
tion including participants with known risk factors for 
CKD (n=24 774) in online supplementary material table 
S1). The mean (standard deviation (±SD)) age of partic-
ipants was 41.5±11.6 years. 88% (4805/5434) of the male 
population was formally employed; 76% (5346/7066) of 
women worked on house duties (ie, housewives). The 
mean BMI was 24±5.0 kg/m2 and mean fat free mass 
was 42±15 kg/m2. The mean fasting plasma glucose was 
91.9±12.3 mg/dL and the mean HbA1c was 5.5%±0.4%. 
The mean systolic and diastolic blood pressures were 
114±12 mm Hg and 74±9 mm Hg, respectively. The 
median (IQR) ACR was 2.4 (4.3) mg/g (after exclusion 
of those with ACR >300 mg/g, n=1208).
Mean eGFr and prevalence of eGFr <60
The mean eGFR was 105.0±17.8 mL/min per 1.73 m2. 
The mean eGFR was lower at increasing ages, in males, in 
inhabitants from rural areas and in those from Northern 
India, in participants with no formal education, and in 
participants who reported tobacco consumption, alcohol 
intake and being vegetarian (table 2). We observed 
differences in mean eGFR depending on the area, being 
104.5±17.6 in urban areas of Northern India, 100.3±16.2 
in rural areas of Northern India, 110.9±15.7 in urban 
areas of Southern India and 97.4±19.8 in the rural area 
of Southern India.
The prevalence of eGFR <60 among the study popu-
lation was 1.6% (95% CI 1.4% to 1.9%). Seventeen per 
cent (95% CI 16% to 17%) of study participants had 
eGFR ≥60–<90 mL/min per 1.73 m2 and 82% (95% CI 
81% to 82%) had eGFR ≥90 mL/min per 1.73 m2. The 
prevalences of different categories of eGFR differed by 
formal education, tobacco consumption, alcohol intake 
and vegetarianism (table 2). Also, we observed marked 
differences in the prevalence of eGFR <60 depending on 
the area, being 1.4% (95% CI 1.1% to 1.8%) in urban 
areas of Northern India, 1.9 (95% CI 1.4 to 2.6) in rural 
areas of Northern India, 0.43% (95% CI 0.03% to 0.07%) 
in urban areas of Southern India and 4.8% (95% CI 
3.9% to 5.9%) in the rural area of Southern India. The 
prevalence ratio of eGFR <60 for rural versus urban resi-
dence was higher in participants younger than 50 years 
(prevalence ratio in age group ≤39=5.5, and prevalence 
ratio in age group 40–49=5.8) than in older participants 
(figure 2).
risk factors for lower eGFr and eGFr <60
As expected, age was an important risk factor for reduced 
eGFR: eGFR was 9.30 mL/min per 1.73 m2 (95% CI −9.51 
to –9.09, model adjusted for sex) lower for each addi-
tional 10 years of age. Additionally, being male, living in 
a rural setting and consuming alcohol were associated 
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with decreased mean eGFR (table 3). Similarly, the odds 
of eGFR <60 also increased with age (OR per 10 years, 
adjusted for sex (95% CI)=2.34 (2.12 to 2.59)) and 
being male, living in a rural setting, living in Southern 
India and consuming alcohol were also associated with 
eGFR <60 (table 3). In general, risk factors for decreased 
mean eGFR and for eGFR <60 were similar for men and 
women (online supplementary material table S2), but few 
differences were observed. Regarding mean eGFR, living 
in Southern India was associated with decreased mean 
eGFR in men and with increased mean eGFR in women; 
tobacco consumption was associated with increased mean 
eGFR in men and with decreased mean eGFR in women; 
vegetarianism was associated with decreased mean eGFR 
in women but not in men; and being overweight was asso-
ciated with decreased mean eGFR but in men but not in 
women. Regarding risk of eGFR <60, living in Southern 
India was associated with increased risk of eGFR <60 in 
men but not in women.
In the multiple regression analyses, decreased mean 
eGFR remained associated with older age, being male, 
living in a rural setting and alcohol consumption (table 4). 
Risk of eGFR <60 remained associated with older age, 
being male and living in a rural setting, and having no 
formal education (table 4). We adjusted all the multiple 
regression models for fat-free mass and vegetarianism to 
assess the possibility that differences observed between 
urban and rural participants were due to differences in 
diet and/or body composition. These adjustments had 
little effect on the results (table 4).
We observed an interaction between the effects of 
latitude (North/South) and urban/rural residence in 
association with reduced eGFR (p value for interac-
tion <0.001). The mean eGFR was lower in rural settings 
in both Northern and Southern India (controlling for 
age, sex, education and alcohol intake). However, this 
decrease was much more marked in Southern India. In 
Northern India, rural residence, formal education (and 
Figure 1 Study flow chart. ACR, albumin:creatinine ratio; CARRS, Centre for Cardiometabolic Risk Reduction in South Asia; 
eGFR, estimated glomerular filtration rate; ICMR-CHD, Indian Council of Medical Research Coronary Heart Disease.
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Table 2 Sociodemographic and anthropometric characteristics of study participants (population without diabetes, 
hypertension or heavy proteinuria)
Variable n (%)* n=12 500
eGFR eGFR categories, n (%) †
mean (SD) ≥90 90–60 <60
Sociodemographic
Age (years)
  ≤39 6121 (49) 113.8 (14.6) 5656 (92) 443 (7) 22 (0)
  40–49 3476 (28) 102.5 (14.2) 2864 (82) 572 (16) 40 (1)
  50–59 1706 (14) 93.9 (14.3) 1163 (68) 503 (29) 40 (2)
  60–69 893 (7) 85.3 (16.2) 463 (52) 368 (41) 62 (7)
  ≥70 304 (2) 77.5 (15.1) 62 (20) 201 (66) 41 (13)
Sex
  Female 7066 (57) 107.9 (17.1) 6039 (85) 945 (13) 82 (1)
  Male 5434 (43) 101.3 (17.9) 4169 (77) 1142 (21) 123 (2)
Education (number completed years)
  0 2820 (23) 100.7 (19.0) 2165 (77) 551 (20) 104 (4)
  ≤5 1709 (14) 105.9 (17.3) 1412 (83) 273 (16) 24 (1)
  6–≤10 4817 (39) 107.2 (16.8) 4095 (85) 675 (14) 47 (1)
  >10 3154 (25) 105.0 (17.5) 2536 (80) 588 (19) 30 (1)
Area ‡
  Urban 8494 (68) 107.8 (16.1) 7247 (85) 1171 (14) 76 (1)
  Rural 4006 (32) 99.0 (18.0) 2961 (74) 916 (23) 129 (3)
Latitude §
  North 6263 (50) 103.0 (17.2) 4967 (79) 1197 (19) 99 (2)
  South 6237 (50) 107.0 (18.1) 5241 (84) 890 (14) 106 (2)
Life-style factors
Current tobacco consumption
  No 9357 (75) 106.8 (17.3) 7836 (84) 1406 (15) 115 (1)
  Yes 3143 (25) 99.8 (18.1) 2372 (75) 681 (22) 90 (3)
Alcohol consumption ever
  No 10 094 (81) 105.9 (17.4) 8362 (83) 1589 (16) 143 (1)
  Yes 2406 (19) 101.1 (18.5) 1846 (77) 498 (21) 62 (3)
Vegetarian
  No 7972 (64) 107.0 (18.0) 6690 (84) 1154 (14) 128 (2)
  Yes 4528 (36) 101.6 (16.6) 3518 (78) 933 (21) 77 (2)
Biological factors
Body mass index (kg/m2)
  Underweight (≤18.5) 5879 (47) 104.2 (17.9) 4734 (81) 1029 (18) 116 (2)
  Normal (>18.5–≤25) 1576 (13) 104.7 (19.3) 1283 (81) 257 (16) 36 (2)
  Overweight (>25–≤30) 3313 (27) 105.0 (16.9) 2710 (82) 568 (17) 35 (1)
  Obese (>30) 1150 (9) 105.5 (16.4) 948 (82) 194 (17) 8 (1)
  Missing data 582 (5) 533 (92) 39 (7) 10 (2)
Fat free mass (kg)
  First tertile (≤37) 3746 (30) 106.6 (18.1) 3146 (84) 532 (14) 68 (2)
  Second tertile (>37 -<45) 3801 (30) 105.9 (17.2) 3145 (83) 601 (16) 55 (1)
  Third tertile (≥45) 3834 (31) 102.1 (17.0) 2981 (78) 801 (21) 52 (1)
  Missing data 1119 (9) 936 (84) 153 (14) 30 (3)
* Percentages in columns.
† Percentages in rows.
‡ Urban areas include Delhi, Chennai and Sonipat district. Rural areas include Sonipat, Vishakhapatnam and Faridabad districts.
§ North areas include Delhi, Sonipat and Faridabad district. South areas include Chennai and Vishakhapatnam districts.
eGFR, estimated glomerular filtration rate.
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duration) and age were the only other risk factor associ-
ated with reduced eGFR. In Southern India, being male 
was also a risk factor for reduced eGFR, whereas formal 
education was only a risk factor for reduced eGFR among 
those with more than 10 years of schooling (table 5). We 
also observed an interaction between the effects of lati-
tude (North/South) and urban/rural residence in asso-
ciation with eGFR <60 (p value likelihood-ratio test for 
interaction <0.001). In Northern India, eGFR <60 was not 
associated with urban/rural residence, and older age was 
the only factor associated with eGFR <60. In Southern 
India, rural residence was the strongest risk factor for 
eGFR <60 but older age and lower years of formal educa-
tion also increased the risk of eGFR <60 (table 5).
sensitivity analyses
We performed a sensitivity analysis including those with 
ACR >300 (but without hypertension or diabetes, n=33) as 
we were concerned that those with CKDu might develop 
proteinuria at more advanced CKD stages. However, 
this did not alter the mean eGFR (mean eGFR among 
the overall study population=105.0±17.8, mean eGFR in 
this sensitivity analysis=105.0±17.8), nor the estimated 
prevalence of eGFR <60 (prevalence among the overall 
study population=1.6%; prevalence in this sensitivity anal-
ysis=1.7%). The findings on risk factors were also similar 
to the findings from the primary analyses (online supple-
mentary material table S3).
Given concerns about potentially different thresholds 
to define diabetes and high blood pressure in different 
ethnic groups,29 30 we performed a further sensitivity anal-
ysis including fasting plasma glucose, HbA1c and systolic 
blood pressure in the multivariate model (even though 
there is evidence for both causation and reverse causation 
between these factors and CKD31). Systolic blood pressure 
and fasting plasma glucose were associated with reduced 
eGFR in this non diabetic population, but inclusion of 
these variables did not alter the coefficients for the asso-
ciations with other risk factors observed in the primary 
analysis (online supplementary material table S4). HbA1c 
was associated with eGFR <60 in this non diabetic popu-
lation but inclusion of this variable did not alter the OR 
for other risk factors observed in the primary analysis 
(online supplementary material table S4). Therefore, 
although the relationship between subclinical diabetes 
and impaired kidney function requires further prospec-
tive investigation, there is no evidence that the excess risk 
of low eGFR (ie, lower mean eGFR and higher prevalence 
of eGFR <60) in rural Southern India is associated with 
either impaired fasting glucose or higher blood pressure.
DIsCussIOn
We report the distribution of eGFR in people without 
diabetes, hypertension or heavy proteinuria and esti-
mate the prevalence of CKDu in our study population, 
including participants from urban and rural settings. This 
is the first population-based evidence, using standardised 
methods, which indicates that CKDu is present in India 
and is not confined to Central America and Sri Lanka. 
We found that the rural population from Southern 
India (Vishakhapatnam district) had the highest risk of 
decreased eGFR (lower mean eGFR and higher prev-
alence of eGFR <60). Risk factors of decreased eGFR 
were different between Southern and Northern India. 
In Southern India, rural residence, older age and being 
male were risk factors for both lower mean eGFR and 
eGFR <60; education was associated with decreased risk 
for eGFR <60 but not with lower mean eGFR. In Northern 
India, older age was the only risk factor for both lower 
mean eGFR and eGFR <60; rural residence and years of 
formal education were associated with lower mean eGFR 
but not with eGFR <60. In summary, in Southern India, 
older age, being male and rural residence were the main 
risk factors for decreased eGFR, whereas in Norther India 
older age was the main risk factors for decreased eGFR.
As in Central America, the risk of low eGFR was higher 
in rural settings than in urban settings. This is in concor-
dance with a previous study from Hyderabad (India), that 
has provided evidence of a higher risk of low eGFR in 
a rural population compared with urban-migrant and to 
urban population,32 and with various studies from other 
LMICs that have provided evidence of clusters of CKDu 
among the rural population.2 3 Exposure to some of the 
suggested potential risk factors for CKDu such as agricul-
tural work and agrochemical exposure, among others,33 
may be greater in rural settings. Such exposures may 
also differ between Southern and Northern India, and 
potentially explain the differences observed between 
these areas. The associations between urban/rural resi-
dence and lower mean eGFR was much more marked in 
Southern India than in Northern India, and the associ-
ations between urban/rural residence and eGFR <60 
was only observed in Southern India. The higher preva-
lence ratio (for eGFR <60) in the working age population 
compared with older age groups is consistent with the 
hypothesis that deceased in eGFR could be potentially 
explained by occupational exposures. The suggestive sex 
differences may also support this hypothesis. However, we 
Figure 2 Prevalence ratio of estimated glomerular filtration 
rate <60 for rural versus urban residence in different age 
groups.
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Table 3 Associations between sociodemographic and anthropometric characteristics and eGFR and eGFR <60
Variable
eGFR eGFR<60
Coefficient (95% CI) * OR (95% CI) *
Age (years) †
  ≤39 0.00 (ref) 1.00 (ref)
  40–49 −11.08 (–11.68 to –10.47) 3.15 (1.87 to 5.32)
  50–59 −19.43 (–20.20 to –18.65) 6.41 (3.80 to 10.83)
  60–69 −27.84 (-28.86 to –26.82) 19.68 (12.01 to 32.26)
  ≥70 −35.04 (–36.71 to –33.37) 39.23 (22.87 to 67.23)
Sex ‡
  Female 0.00 (ref) 1.00 (ref)
  Male −3.55 (−4.05 to –3.06) 1.33 (0.99 to 1.78)
Education (number of completed years)
  0 0.00 (ref) 1.00 (ref)
  ≤5 1.92 (1.09 to 2.76) 0.41 (0.26 to 0.65)
  6–≤10 1.27 (0.61 to 1.93) 0.36 (0.25 to 0.53)
  >10 −1.86 (–2.59 to –1.14) 0.40 (0.26 to 0.62)
Area §
  Urban 0.00 (ref) 1.00 (ref)
  Rural −3.84 (−4.37 to –3.32) 2.39 (1.78 to 3.22)
Latitude ¶
  North 0.00 (ref) 1.00 (ref)
  South 0.86 (0.37 to 1.35) 1.55 (1.16 to 2.07)
Current tobacco consumption
  No 0.00 (ref) 1.00 (ref)
  Yes 0.38 (-−0.26 to 1.02) 1.39 (1.01 to 1.91)
Alcohol consumption ever
  No 0.00 (ref) 1.00 (ref)
  Yes −0.81 (−1.55 to –0.08) 1.57 (1.09 to 2.27)
Vegetarian
  No 0.00 (ref) 1.00 (ref)
  Yes −0.99 (−1.50 to –0.47) 0.65 (0.48 to 0.88)
Body mass index (kg/m2)
  Underweight (≤18.5) 2.96 (2.20 to 3.73) 0.81 (0.55 to 1.20)
  Normal (>18.5–≤25) 0.00 (ref) 1.00 (ref)
  Overweight (>25–≤30) −0.75 (−1.34 to –0.16) 0.68 (0.46 to 1.01)
  Obese (>30) −0.71 (−1.59 to 0.17) 0.47 (0.23 to 0.98)
Fat-free mass (kg)
  1st tertile (≤37) 0.00 (ref) 1.00 (ref)
  2nd tertile (>37–<45) −0.91 (−1.54 to –0.28) 0.69 (0.47 to 1.03)
  3rd tertile (≥45) −3.90 (−4.77 to –3.04) 0.49 (0.31 to 0.80)
*Adjusted for age and sex.
†Adjusted just for sex.
‡Adjusted just for age.
§Urban areas include Delhi, Chennai and Sonipat district. Rural areas include Sonipat, Vishakhapatnam and Faridabad districts.
¶ North areas include Delhi, Sonipat and Faridabad district. South areas include Chennai and Vishakhapatnam districts.
eGFR, estimated glomerular filtration rate.
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did not have detailed data on occupation that allowed us 
to explore these associations in greater detail.
The higher risk of low eGFR in Southern India 
(Chennai and Vishakhapatnam districts) observed in our 
study is consistent with the clusters of CKDu cases previ-
ously reported in the Southern Indian states of Andhra 
Pradesh and Odisha.11 18 19 Vishakhapatnam district 
(state of Andhra Pradesh) and Chennai district (state 
of Tamil Nadu) have a similar climate than these areas 
where CKDu clusters have previously reported.34 In these 
districts, mean temperatures range from 18°C to 37°C 
and rainfall occurs mainly between June and December.35 
On the other hand, sites from Norther India included in 
the study (Delhi (National Capital Territory of Delhi)), 
Sonipat and Faridabad (Haryana state)), have a different 
climate. In these districts mean temperature ranges from 
8°C to 39°C and precipitation occurs mainly between 
July and August.35 A previous study conducted in Costa 
Rica found a spatial correlation between rates of CKD 
mortality and temperature and rainfall.13
About 5% of the rural population of Vishakhapatnam 
(Andra Pradesh, Southern India) without diabetes, hyper-
tension or proteinuria had eGFR <60. This figure is almost 
as high as the prevalence observed in the USA (ie, 6.7%) 
including people with diabetes, hypertension or protein-
uria.36 Moreover, the estimates of GFR in our study are 
likely to be underestimated. The CKD-EPI equation has 
been standardised for the white and Afro-American popu-
lation,23 but its validity for other ethnic groups has been 
questioned.37 38 Previous studies using CKD-EPI equation to 
estimate GFR in Indian populations reported mean eGFR 
values similar to the mean eGFR reported in our study (ie, 
104.9±25.52 mL/min/1.73 m2).39 However, two studies 
conducted among healthy kidney donors in India (popula-
tion similar to those included in this analysis) have reported 
mean (measured) GFR between 81.4 and 95.5 mL/min per 
1.73 m2,40 41 suggesting that the CKD-EPI equation substan-
tially overestimates eGFR in the Indian population. There-
fore, the prevalence of eGFR <60 observed in this study 
is likely to be substantially underestimated (although this 
is unlikely to have biased the internal comparisons, eg, 
between urban and rural settings). The use of a conserva-
tive definition of the population susceptible to CKDu, may 
have also underestimated the prevalence of eGFR <60 in 
our study, as the population with diabetes, hypertension 
or glomerular disease may also have reduced eGFR due 
to other (‘unknown’) causes. To estimate the actual preva-
lence of reduced eGFR, future studies should include vali-
dated methods to estimate GFR in the Indian population. 
We were concerned that the validity of CKD-EPI among 
the Indian population may be also compromised by differ-
ences in muscular mass and meat consumption between 
Table 5 Multivariate analysis of sociodemographic characteristics associated with eGFR and with eGFR <60 according to 
latitude*
Variables
eGFR (n=12 500) eGFR<60(n=12 500)
North (n=6263) † South (n=6237) ‡ North (n=6263) † South (n=6237) ‡
Coefficient (95% CI) Coefficient (95% CI) OR (95% CI) OR (95% CI)
Area §
  Urban 0.00 (ref) 0.00 (ref) 1.00 (ref) 1.00 (ref)
  Rural −1.42 (−2.15 to 0.70) −7.90 (−8.81 to 7.00) 0.88 (0.57 to 1.37) 4.68 (2.50 to 8.77)
Education (number of 
completed years)
  0 0.00 (ref) 0.00 (ref) 1.00 (ref) 1.00 (ref)*
  ≤5 −1.32 (−2.58 to 0.05) 1.05 (−0.06 to 2.16) 1.16 (0.57 to 2.35) 0.40 (0.20 to 0.80)
  6–≤10 −3.50 (−4.48 to 2.52) 0.28 (−0.74 to 1.30) 1.34 (0.74 to 2.41) 0.35 (0.16 to 0.74)
  >10 −6.93 (−7.97 to 5.89) −2.85 (−4.03 to 1.67) 1.34 (0.69 to 2.58) 0.61 (0.24 to 1.57)
Alcohol consumption ever
  No 0.00 (ref) 0.00 (ref) 1.00 (ref) 1.00 (ref)
  Yes −0.54 (−1.55 to 0.47) −0.06 (−1.11 to 0.99) 1.09 (0.62 to 1.92) 1.36 (0.74 to 2.17)
Sex
  Female 0.00 (ref) 0.00 (ref) 1.00 (ref) 1.00 (ref)
  Male −0.17 (−0.96 to 0.63) −5.40 (−6.29 to 4.51) 0.97 (0.59 to 1.59) 1.58 (0.91 to 2.75)
Age (per 10 years) −9.26 (−9.55 to 8.97) −8.96 (−9.28 to 8.64) 2.51 (2.15 to 2.93) 2.10 (1.77 to 2.50)
*Likelihood ratio test for linear trend <0.05, OR (95% CI)=0.68 (0.51 to 0.91).
†North areas include Delhi, Sonipat and Faridabad district.
‡South areas include Chennai and Vishakhapatnam districts.
§Urban areas include Delhi, Chennai and Sonipat district. Rural areas include Sonipat, Vishakhapatnam and Faridabad districts.
eGFR, estimated glomerular filtration rate.
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population groups within India. We adjusted the analyses 
for fat free mass and vegetarianism, but this did not alter the 
results, suggesting no confounding effect by these variables.
Our study has at least three potential limitations. First, 
we only had one measure of eGFR, and therefore we could 
not differentiate acute kidney injury (AKI) from CKD. 
This is a common limitation in epidemiological studies, 
as it is challenging to obtain more than one measure of 
eGFR at least 3 months apart in large population-based 
investigations. Therefore, we may have misclassified some 
cases of AKI as reduced eGFR, and therefore overestimate 
the prevalence of this condition. Nevertheless, there is no 
a priori reason to think that potential misclassification was 
different according to the evaluated risks factors. Second, 
the three population-based studies included in this anal-
ysis used different sampling strategies. CARRS and UDAY 
studies included only one man and one woman from all 
the eligible participants of selected households, whereas 
ICMR-CHD included all eligible adults from each 
selected household. This could have slightly biased our 
results (including our prevalence estimates) if risk factors 
potentially associated with CKDu were different between 
households inhabited only by a man and a women or by 
extended families. Third, information on other potential 
risk factors for CKDu, such as infections by Leptospora or 
hantavirus infection, or use of non-steroidal anti-inflam-
matory drugs was not available.
The main strengths of the study are the use of a random 
selection of population-based participants and a large 
sample size including participants from different areas 
of India (urban and rural, and Northern and Southern 
India). Moreover, we used the definitions proposed in 
DRGREE study,42 that aims to allow international compar-
isons of CKDu prevalence and help in the description of 
risk factors and in identifying the causes and mechanisms 
leading to CKDu.
In conclusion, our findings indicate that reduced 
eGFR, consistent with the definition of CKDu, is common 
in rural settings of Southern India (Vishakhapatnam 
district). This results support the hypothesis that the 
epidemic of CKDu, initially described in agricultural 
communities of Central America and Sri Lanka, may be 
common in other rural communities of tropical/subtrop-
ical countries. This has important implications for global 
health, since it indicates that CKDu may have a substan-
tial public health burden globally that has been previ-
ously unrecognised. Population-based studies in other 
tropical/subtropical countries are required to assess the 
global patterns of burden of disease from CKDu.42 
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